Depression Management Case February Patient Case
|
|
- Angelina Dickerson
- 5 years ago
- Views:
Transcription
1 Depressin Management Case February 2017 Patient Case NW is an 80-year-ld female admitted t hspice yesterday with a primary diagnsis f cngestive heart failure. Her c-mrbidities include hypertensin and crnary artery disease. She has allergies t penicillin, which caused a rash, and lrazepam with reprted cnfusin. She was recently started n dulxetine by her family dctr t manage cnstant wrry, irritability and sadness. NW lives with her daughter wh als reprts that her mther has truble sleeping due t these recent symptms. Current medicatins include: Amldipine (Nrvasc ) 5mg; 1 tab p daily fr bld pressure Carvedill (Creg ) 3.125mg; 1 tab p BID fr heart failure Clpidgrel (Plavix ) 75mg; 1 tab p daily fr clt preventin Digxin (Lanxin ) 0.125mg; 1 tab p daily fr heart failure Dulxetine (Cymbalta ) 30mg; 1 cap p daily fr md Fursemide (Lasix ) 40mg; 1 tab p BID fr fluid retentin Mrphine (Rxanl ) 20mg/ml; 25ml p/sl every 3 hurs PRN pain r shrtness f breath Spirnlactne (Aldactne ) 25mg; 1 tab p daily fr fluid retentin Albuterl (Ventlin ) inhaler; Inhale 2 puffs p q4h PRN shrtness f breath NW s bld pressure is currently cntrlled and lwer extremity edema that has been a prblem in the past, is being managed well with her diuretics. Her family reprts that she frequently gets up t use the bathrm at night. She experiences shrtness f breath with activity and uses an albuterl inhaler as needed. She uses mrphine 1-2 times per day fr pain with gd respnse. She has a histry f becming cnfused with lrazepam, hwever, her family states that she has tlerated ther benzdiazepines in the past. The dulxetine that was started tw weeks ag by her family dctr has already imprved NW s md, hwever, she cntinues t have prblems sleeping. Dulxetine is nt n the hspice pharmacy s frmulary, but the frmulary includes a number f SSRIs. WHAT ARE SYMPTOMS OF DEPRESSION AT END-OF-LIFE? Depressin is a medical illness that invlves bth the mind and bdy. Hspice patients may face a greater likelihd f develping r wrsening a clinical diagnsis f depressin due t the awareness f their limited lifespan. Cmmn symptms include feelings f sadness/unhappiness, irritability, lss f interest/pleasure in nrmal activities, insmnia r excessive sleeping, changes in appetite r an increased craving fr fd, and agitatin. Other symptms include slwed thinking r bdy mvements (psychmtr slwing), decreased cncentratin, fatigue, lss f energy, feelings f wrthlessness r guilt, frequent thughts f death, crying spells and unexplained physical prblems. Due t its symptms, depressin has a negative impact n quality f life and untreated depressin leads t significant mrbidity and mrtality als negatively affects caregivers. In sme peple, depressin is als assciated with an increased desire fr hastened death Enclara Pharmacia. All rights reserved. 1
2 WHAT MUST BE ASSESSED BEFORE INITIATING AN ANTIDEPRESSANT? Befre initiating drug therapy, it is imprtant t rule ut ther factrs such as medicatins r cmrbidities that may be causing r wrsening depressin. Review the medicatin list and try t relate changes in medicatin t the nset f the symptms and rule ut ther secndary causes such as: C-mrbidities: Anemia, cancer, cardiac disease, endcrine disrders, infectins, metablic disrders, neurlgical disrders Medicatins: Baclfen, barbiturates, benzdiazepines, beta-blckers, clnidine, crticsterids, diuretics, piids Other: Alchlism, psychscial issues, pain, insmnia Evaluate patient with DSM-IV criteria r utilize anther depressin screening assessment tl r simply ask the patient, Are yu depressed? Cnsider the fllwing as a part f a differential diagnsis and recgnize that prgnsis will affect treatment appraches: 1 Majr depressive disrder: Treat with drug therapy plus psychtherapy Unspecified depressive disrder: Cntinually assess; May treat with drug therapy plus psychtherapy Adjustment disrder with depressed md: Treat with supprtive cunseling aimed at cping skills and prblem slving aimed at reslving r remving stressr Grief: Treat with supprtive cunseling r psychtherapy Demralizatin: Treat with supprtive cunseling r psychtherapy HOW DO I CHOSE THE RIGHT ANTIDEPRESSANT? 1-3 Depressin may be mediated by the depletin f several neurtransmitters including nrepinephrine, sertnin, and dpamine. Antidepressants affect hw these neurtransmitters behave, but hw they imprve symptms is nt well understd. All antidepressants have similar efficacy, s chse an agent based n patient histry and cmrbidities, prgnsis, side effects and tlerability, ptential drug interactins and cst. All agents prvide sme symptm imprvement in the initial weeks f therapy, hwever, it may take 1-2 mnths f dse titratin and system acclimatin fr patients t experience the full extent f benefits. Reserve antidepressants fr patients with terminal cnditins that have lnger prgnses. Cmmn undesired effects (r desirable effects in sme cases) that may help t distinguish the best agent fr yur patient include sexual dysfunctin, weight gain, sleep, energy, anxiety and pain. Nte that the mnamine xidase inhibitr (MAOI) class f antidepressants (phenelzine (Nardil ), (tranylcyprmine (Parnate ) is typically nt used as initial therapy in the general ppulatin nr initiated in hspice. Please cnsult yur pharmacist fr guidance if yur patient is taking an MAOI. Selective Sertnin Reuptake Inhibitrs (SSRIs) Agents: Citalpram (Celexa ), Escitalpram (Lexapr ), Fluxetine (Przac ), Fluvxamine (Luvx ), Parxetine (Paxil ), Sertraline (Zlft ) 2017 Enclara Pharmacia. All rights reserved. 2
3 Indicated fr: Prgnsis ~ 6 mnths Cnsider fr: Cncmitant anxiety, psychmtr slwing Avid/Cautin in: Cncmitant agitatin, insmnia (particularly fluxetine and sertraline), sexual dysfunctin cncerns Ntes: Citalpram and sertraline have lwer ptential fr drug-drug interactins. Fluxetine and Parxetine have a higher ptential fr drug-drug interactins. Other Agents similar t SSRIs Agent: Vrtixetine (Trintellix ) Indicated fr: Prgnsis ~ 6 mnths Cnsider fr: Cncmitant psychmtr slwing Avid/Cautin in: Nausea cncerns Ntes: Cmbinatin sertnin reuptake inhibitr and sertnin receptr antagnist Agent: Vilazdne (Viibryd ) Indicated fr: Prgnsis ~ 6 mnths Ntes: Cmbinatin sertnin reuptake inhibitr and sertnin receptr partial agnist Selective Nrepinephrine Reuptake Inhibitrs (SNRIs) Agents: Dulxetine (Cymbalta ), Venlafaxine (Effexr ), Desvenlafaxine (Pristiq ), Levmilnacipran (Fetzima ) Indicated fr: Prgnsis ~ 6 mnths Cnsider fr: Cncmitant neurpathic pain, psychmtr slwing, anxiety Avid/Cautin in: Hypertensin, agitatin r insmnia, sexual dysfunctin cncerns Hetercyclic Antidepressants Agents: Mirtazapine (Remern ), Trazdne (Desyrel ) Indicated fr: Prgnsis ~ 6 mnths Cnsider fr: Cncmitant insmnia (mirtazapine, trazdne), appetite lss (mirtazapine), agitatin (mirtazapine), sexual dysfunctin cncerns Avid/Cautin in: Overweight cncerns Ntes: Nt cnsidered first-line therapy withut cncmitant indicatins fr use. Tricyclic Antidepressants (TCAs) Agent: Amitriptyline (Elavil ), Desipramine (Nrpramin ), Dxepin (Sinequan ), Imipramine (Tfranil ), Nrtriptyline (Pamelr ) Indicated fr: Prgnsis ~ 6 mnths Cnsider fr: Cncmitant insmnia and/r neurpathic pain 2017 Enclara Pharmacia. All rights reserved. 3
4 Avid/Cautin in: Structural heart disease, cncmitant medicatins that prlng QT interval Ntes: Nt cnsidered first-line therapy. Antichlinergic prperties may be prly tlerated by geriatric patients. Aminketnes Agents: Buprprin (Wellbutrin, Wellbutrin SR, Wellbutrin XL) Indicated fr: Prgnsis ~ 6 mnths Cnsider fr: Patients with lw energy (mild stimulant effects), verweight cncerns, sexual dysfunctin cncerns Avid/Cautin in: Seizure histry (decreases seizure threshld), patients with insmnia Ntes: Adjunct therapy ONLY. Psychstimulants Agent: Methylphenidate (Ritalin ) Indicated fr: Prgnsis 6 mnths Cnsider fr: Patients with shrt prgnsis and gals cnsistent with maintaining alertness and energy level Avid/Cautin in: Cncmitant anxiety, agitatin, appetite lss Ntes: Onset within a few days & limited t several-week effectiveness with side effects increasing ver time. Mst effective fr shrt-term treatment f refractry depressin. HOW DO I MANAGE SWITCHING FROM ONE ANTIDEPRESSANT TO ANOTHER? When changing frm ne antidepressant t anther (fr example, t a medicatin included in the hspice frmulary), cnsider the patient s histry and prgnsis first. If a patient has a histry f depressin and symptms have been stabilized n their current medicatin, it may be mre beneficial fr the patient t cntinue that medicatin, especially if prgnsis is days t weeks. If symptms are new and/r the patient has been n an antidepressant fr a shrt time and prgnsis is mnths, switching agents may be mre apprpriate. Mnitr the patient and adjust the switching strategy fr symptms f withdrawal, side effects, r the return f symptms f depressin. 2,3 Guide fr switching frm ne agent t anther: Cnservative switch r Mderate switch Gradually decrease and then d/c the ld agent fllwed by a washut perid befre initiating the new agent. Washut perids are drug-specific and shuld allw time fr the discntinued medicatin t be eliminated frm the patient s system. Full eliminatin is estimated by calculating 5 times the drug s t 1/2 (eliminatin half-life) (the time it takes fr the plasma cncentratin f the drug in the bdy t decrease by half) (i.e., dulxetine s t 1/2 averages 12.5 hurs s the washut perid wuld be 62.5 hurs (apprx. 3 days). This apprach is nt practical r recmmended in hspice. Discntinuatin f ne agent, leaving a gap f time befre starting anther agent, can cause discntinuatin syndrme (dizziness, 2017 Enclara Pharmacia. All rights reserved. 4
5 irritability, nausea, fatigue) r symptm recurrence. Discntinuatin syndrmes are f mst cncern when switching frm a sertnergic agent (i.e., SSRI, SNRI) t a nn-sertnergic agent (i.e., hetercyclic, TCA). 2. Direct r Next Day switch Apprpriate fr when the ld agent and new agent are in the same class r similar classes (i.e., SSRIs and SNRIs). Last dse f ld drug taken ne day and then new drug initiated at the same time f day the next cnsecutive day at a lw dse. Gradually increase t effect. Nte that Fluxetine has a lng half-life, s wait 4-7 days befre starting new agent if fluxetine is the ld drug. 3. Crss-taper switch Apprpriate fr when the ld drug and new drug are NOT in the same class and fr patients at high risk f symptm/illness relapse. Crss-tapering invlves gradually increasing the new drug while decreasing the ld drug s that patient is taking bth antidepressants simultaneusly. Tapering dwn ld agent example: Decrease dse by 25% every week until dse is at a lw/initial starting dse (i.e., fr Sertraline 100mg Daily - Week 1: 75mg/day, Week 2: 50mg/day, Week 3: 25mg/day, Week 4: D/C) Gradually increasing new agent example: Increase dse by 25% every week until dse is at therapeutic dse (i.e., fr Mirtazapine - Week 1: 7.5mg/day, Week 2: 15mg/day, Week 3: 30mg/day, Week 4: Cntinue 30mg/day if therapeutic r cnsider increase t 45mg/day) Drug-specific ntes: 1. Taper/gradually increase parxetine ver at least 4 weeks. 2. Taper/gradually increase ther SSRIs, venlafaxine, and dulxetine ver a ttal f 1-4 weeks Sertraline r venlafaxine, by 25 t 50 mg/day every 1-2 weeks Parxetine r citalpram by 5 t 10 mg/day every 1-2 weeks Escitalpram by 5 mg/day every 1-2 weeks 3. Literature is lacking fr switching t/frm vilazdne r vrtixetine t anther agent. Cnsider managing the same as SSRIs due t sertnergic mechanism. Fllw manufacturer s recmmended titratin schedule when starting vilazdne. 4. Literature is lacking fr switching t/frm desvenlafaxine r levmilnacipran t anther agent. Cnsider managing as venlafaxine due t similar mechanism f actin. PHARMACIST ASSESSMENT NW has cardiac disease in which depressin is cmmn. Her medicatin list cntains drugs that may precipitate depressin symptms (carvedill, fursemide, spirnlactne, mrphine) hwever, she has been n these medicatins fr sme time nw and her depressive symptms started recently. Her ther symptms, including pain and breathlessness, are generally well cntrlled. Based n assessment in cllabratin with the hspice medical directr, it is determined that the patient is experiencing a new nset unspecified depressive disrder. NW has been taking dulxetine fr tw weeks and her prgnsis is estimated t be several mnths. The hspice wishes t switch t a frmulary medicatin and the family agrees Enclara Pharmacia. All rights reserved. 5
6 RECOMMENDATIONS 1. Assess timing f fursemide dsing t prevent nighttime waking t use bathrm. Cnsider timing 2 nd fursemide dse in the afternn t minimize nighttime disruptin f sleep. 2. NW has had a psitive initial respnse t dulxetine. T minimize discntinuatin symptms, switching t an agent with sertnergic prperties will prvide a smth transitin. 3. Direct r Next Day switch: When patient/family is ready, have NW take the last dse f dulxetine n Day 1. At the same time f day n Day 2, begin citalpram 20mg p daily. FOR ADDITIONAL INFORMATION ON THIS TOPIC, PLEASE REVIEW THESE REFERENCES: Enclara Pharmacia s On Demand Educatinal Webinar, Delirium, Depressin and Anxiety at End f Life. 1. Fairman N, Hirst JM, Irwin SA. Clinical manual f palliative care psychiatry. 1 st Arlingtn: American Psychiatric Assciatin; PL Detail-Dcument, Chsing and Switching Antidepressants. Pharmacist s Letter/Prescriber s Letter. July PL Detail-Dcument, Antidepressants. Pharmacist s Letter/Prescriber s Letter. July Keks N, Hpe J, Kegh S. Switching and stpping antidepressants. Aust Prescr 2016;39: Available frm: 5. Clinical Pharmaclgy [database nline]. Tampa, FL: Elsevier/Gld Standard, Inc.; Access 2017 Feb. Available frm: 6. GP Online. Switching and withdrawing antidepressants Marangell LB. Switching antidepressants fr treatment-resistant majr depressin. J Clin Psychiatry 2001;62(Suppl 18): Rsenstein DL. Depressin and end-f-life care f patients with cancer; Dialgues Clin Neursci March;31(1): Available frm: 9. Nrani NH and Mntagnini M. Recgnizing depressin in palliative care patient. Jurnal f Palliative Medicine. 2007;10(2): Hirdes JP, et al. Predictrs f caregiver distress amng palliative hme care clients in Ontari: Evidence based n the interrai Palliative Care. Palliat Supprt Care. 2012;10(3): Wilsn KG, et al. Diagnsis and management f depressin in palliative care, in Handbk f Psychiatry in Palliative Medicine, 2 nd New Yrk: Oxfrd University Press; 2009, pp Rsenfeld B, et al. Des desire fr hastened death change in terminally ill cancer patients? Sc Sci Med.2014;111: Zhang B, et al. Factrs imprtant t patients quality f life at the end f life. Arch Intern Med. 2012;172(15): Enclara Pharmacia. All rights reserved. 6
Depression in the Older Adults. Summary
Depressin in the Older Adults Summary Majr depressive disrder (MDD) is the leading cause f disability accrding t the Wrld Health Organizatin. Cmmn clinical cnditins and previus research has shwn that the
More informationFormulary and Prescribing Guidelines
Frmulary and Prescribing Guidelines SECTION 1: TREATMENT OF DEPRESSION 1.1 Intrductin This guidance shuld be cnsidered as part f a stepped care apprach in the management f depressive disrders. Antidepressants
More informationo I will be discussing off-label use of medications o Describe medication options for depression o Relevant assessment o Current medications
Disclsures I have n persnal r financial cnflicts f interest t disclse I will be discussing ff-label use f medicatins Objectives: Pharmacists Describe fur evidence-based clinical pearls f depressin pharmactherapy
More informationMedication Guide MORPHINE SULFATE (mor-pheen) Oral Solution (CII)
Medicatin Guide MORPHINE SULFATE (mr-pheen) Oral Slutin (CII) IMPORTANT: Keep Mrphine Sulfate Oral Slutin in a safe place away frm children. Accidental use by a child is a medical emergency and can cause
More informationPart 1 describes the reasoning and recommendations up to node 2 of the algorithm.
Presented by: David Osser, MD Assciate Prfessr f Psychiatry Harvard Medical Schl Dr. Osser has n cnflicts f interest t disclse. This dcument is a summary f selected clinical pearls frm Dr. Osser s presentatin:
More informationPresenter disclosures
Presenter disclsures DEPRESSION IN THE ELDERLY Synergize March 3, 2016 Dallas Seitz, MD PhD FRCPC Department f Psychiatry, Queen s University Prvidence Care MHS Faculty: Dallas Seitz Relatinships with
More informationAnnex III. Amendments to relevant sections of the Product Information
Changes t the Prduct infrmatin as apprved by the CHMP n 13 Octber 2016, pending endrsement by the Eurpean Cmmissin Annex III Amendments t relevant sectins f the Prduct Infrmatin Nte: These amendments t
More informationBreast Cancer Awareness Month 2018 Key Messages (as of June 6, 2018)
Breast Cancer Awareness Mnth 2018 Key Messages (as f June 6, 2018) In this dcument there are tw sectins f messages in supprt f Cancer Care Ontari s Breast Cancer Awareness Mnth 2018: 1. Campaign key messages
More informationNew Zealand Consumer Medicine Information. Tramadol hydrochloride immediate release capsules (50 mg) and solution for injection (50 mg/ml, 100 mg/2ml)
New Zealand Cnsumer Medicine Infrmatin TRAMAL Tramadl hydrchlride immediate release capsules (50 mg) and slutin fr injectin (50 mg/ml, 100 mg/2ml) What is in this leaflet Please read this leaflet carefully
More informationObesity/Morbid Obesity/BMI
Obesity/mrbid besity/bdy mass index (adult) Obesity/Mrbid Obesity/BMI Definitins and backgrund Diagnsis cde assignment is based n the prvider s clinical judgment and crrespnding medical recrd dcumentatin
More informationBedfordshire and Hertfordshire DRAFT Priorities forum statement Number: Subject: Prostatism Date of decision: January 2010 Date of review:
Bedfrdshire and Hertfrdshire DRAFT Pririties frum statement Number: Subject: Prstatism Date f decisin: January 2010 Date f review: Referral criteria Mst men with lwer urinary tract symptms due t benign
More informationWARNING: FATAL AND SERIOUS TOXICITIES: SEVERE DIARRHEA AND CARDIAC TOXICITIES
INDICATION FARYDAK (panbinstat) capsules, a histne deacetylase inhibitr, in cmbinatin with brtezmib and dexamethasne, is indicated fr the treatment f patients with multiple myelma wh have received at least
More informationFrequently Asked Questions: IS RT-Q-PCR Testing
Questins 1. What is chrnic myelid leukemia (CML)? 2. Hw des smene knw if they have CML? 3. Hw is smene diagnsed with CML? Frequently Asked Questins: IS RT-Q-PCR Testing Answers CML is a cancer f the bld
More informationPain relief after surgery
Pain relief after surgery Imprtant infrmatin fr patients www.mchft.nhs.uk We care because yu matter This leaflet is designed t help yu cntrl any pain yu may have at hme fllwing yur peratin. Please read
More informationSwindon Joint Strategic Needs Assessment Bulletin
Swindn Jint Strategic Needs Assessment Bulletin Swindn Diabetes 2017 Key Pints: This JSNA gives health facts abut peple with diabetes r peple wh might get diabetes in Swindn. This helps us t plan fr medical
More information/0515 Medication Guide Aripiprazole Tablets
8415721/0515 Medicatin Guide Aripiprazle Tablets (air-eh-pip-rah-zle) Read this Medicatin Guide befre yu start taking aripiprazle tablets and each time yu get a refill. There may be new infrmatin. This
More informationSignificance of Chronic Kidney Disease in 2015
1 Significance f Chrnic Kidney Disease in 2015 There is still a requirement within QOF t keep a register f peple with CKD stages 3-5. The ther CKD QOF targets have been retired. This is because CKD care
More informationo New or sudden changes in mood, behavior, actions, thoughts, or feelings, especially if severe.
MEDICATION GUIDE FLUOXETINE CAPSULES, USP (fl xʹ e teen) 10 mg and 20 mg Read the Medicatin Guide that cmes with fluxetine capsules befre yu start taking it and each time yu get a refill. There may be
More informationBP Thresholds for Medical Review
BP Threshlds fr Medical Review Wmen presents t GP pstnatally with high bld pressure r referred t GP by midwife GP t review patient n the same day if BP>150/100. If BP (dne by midwife) persistently 140-149/90-99,
More informationMEDICATION GUIDE. (fingolimod) capsules
MEDICATION GUIDE GILENYA (je-len-yah) (finglimd) capsules Read this Medicatin Guide befre yu start using GILENYA and each time yu get a refill. There may be new infrmatin. This infrmatin des nt take the
More informationMEDICATION GUIDE Pioglitazone and Metformin Hydrochloride (PYE o GLI ta zone and met FOR min HYE-droe- KLOR-ide)Tablets, USP
MEDICATION GUIDE Piglitazne and Metfrmin Hydrchlride (PYE GLI ta zne and met FOR min HYE-dre- KLOR-ide)Tablets, USP Read this Medicatin Guide carefully befre yu start taking piglitazne and metfrmin hydrchlride
More informationChronic Fatigue Syndrome
Chrnic Fatigue Syndrme (Als knwn as Myalgic encephalmyelitis/encephalmyelpathy) What is CFS/ME? CFS/ME cmprises a range f symptms that include fatigue, malaise, headaches, sleep disturbances, difficulties
More informationQ 5: Is relaxation training better (more effective than/as safe as) than treatment as usual in adults with depressive episode/disorder?
updated 2012 Relaxatin training Q 5: Is relaxatin training better (mre effective than/as safe as) than treatment as usual in adults with depressive episde/disrder? Backgrund The number f general health
More informationMEDICATION GUIDE QSYMIA (Kyoo sim ee uh) (phentermine and topiramate extended-release) Capsules CIV
MEDICATION GUIDE QSYMIA (Ky sim ee uh) (phentermine and tpiramate extended-release) Capsules CIV Read this Medicatin Guide befre yu start taking Qsymia and each time yu get a refill. There may be new infrmatin.
More informationAdvantage EAP Employee Assistance Program
Advantage EAP Emplyee Assistance Prgram July 2014 In This Issue What might we face? Symptms f SAD Seasnal changes in biplar disrder Tips fr cmbating summer truble When t seek help Tips fr helping thse
More information454-8 (Insert) MEDICATION GUIDE ZUBSOLV (Zub-solve) (buprenorphine and naloxone) Sublingual Tablet (CIII) IMPORTANT: Keep ZUBSOLV in a secure place
MEDICATION GUIDE ZUBSOLV (Zub-slve) (buprenrphine and nalxne) Sublingual Tablet (CIII) IMPORTANT: Keep ZUBSOLV in a secure place away frm children. Accidental use by a child is a medical emergency and
More informationMEDICATION GUIDE Pioglitazone (pie-oh-glit-ah-zohn) and Metformin (met-fore-min) Hydrochloride Tablets USP
MEDICATION GUIDE Piglitazne (pie-h-glit-ah-zhn) and Metfrmin (met-fore-min) Hydrchlride Tablets USP Read this Medicatin Guide carefully befre yu start taking piglitazne and metfrmin hydrchlride tablets
More informationYou may have a higher risk of bleeding if you take warfarin sodium tablets and:
MEDICATION GUIDE Warfarin (WAR-far-in) Sdium (SO-dee-um) Tablets USP The 7.5 mg tablets cntain FD&C Yellw N. 5 (tartrazine), which may cause allergic-type reactins (including brnchial asthma) in certain
More informationSuicidal thoughts or actions:
MEDICATION GUIDE Venlafaxine (VEN la fax een) Hydrchlride Extended-release Capsules USP Read the Medicatin Guide that cmes with venlafaxine hydrchlride extended-release capsulesbefre yu start taking them
More informationFTD RESEARCH: The Value of Studies and Opportunities for Involvement
FTD RESEARCH: The Value f Studies and Opprtunities fr Invlvement Sarah Lawrence, MS Research Prgram Manager Ann Fishman, MBA Sr. Research Crdinatr Weiyi Mu, ScM Genetic Cunselr Suzanne Dana Spuse/Caregiver
More informationOsteoporosis Fast Facts
Osteprsis Fast Facts Fast Facts n Osteprsis Definitin Osteprsis, r prus bne, is a disease characterized by lw bne mass and structural deteriratin f bne tissue, leading t bne fragility and an increased
More informationCONSENT FOR KYBELLA INJECTABLE FAT REDUCTION
CONSENT FOR KYBELLA INJECTABLE FAT REDUCTION INSTRUCTIONS This is an infrmed cnsent dcument which has been prepared t help yur Dctr infrm yu cncerning fat reductin with an injectable medicatin, its risks,
More informationBRCA1 and BRCA2 Mutations
BRCA1 and BRCA2 Mutatins ROBERT LEVITT, MD JESSICA BERGER-WEISS, MD ADRIENNE POTTS, MD HARTAJ POWELL, MD, MPH COURTNEY LEVENSON, MD LAUREN BURNS, MSN, RN, WHNP OBGYNCWC.COM v Cancer is a cmplex disease
More informationCompleting the NPA online Patient Safety Incident Report form: 2016
Cmpleting the NPA nline Patient Safety Incident Reprt frm: 2016 The infrmatin cntained within this dcument is in line with the current Data Prtectin Act (DPA) requirements. This infrmatin may be subject
More informationSub-Topic: Massage for Depression, Anxiety, and Sleep Disorders Level 1 Knowledge: Attain and Comprehend Skills: Observe and Imitate
Nte: Feedback frm prfessin stakehlders n the first draft f the Entry-Level Massage Educatin Blueprint indicated that this sub-tpic was beynd entry-level r unnecessary fr safe and cmpetent practice. The
More informationPennsylvania Guidelines on the Use of Opioids to Treat Chronic Noncancer Pain
Pennsylvania Guidelines n the Use f Opiids t Treat Chrnic Nncancer Pain Chrnic pain is a majr health prblem in the United States, ccurring with a pintprevalence f abut ne-third f the US ppulatin.(1) Mre
More informationPART III: CONSUMER INFORMATION
IMPORTANT: PLEASE READ PART III: CONSUMER INFORMATION Pr ZERIT Stavudine This leaflet is Part III f a three-part Prduct Mngaph published when ZERIT was apprved fr sale in Canada and is designed specifically
More informationA Phase I Study of CEP-701 in Patients with Refractory Neuroblastoma NANT (01-03) A New Approaches to Neuroblastoma Therapy (NANT) treatment protocol.
SAMPLE INFORMED CONSENT A Phase I Study f CEP-701 in Patients with Refractry Neurblastma NANT (01-03) A New Appraches t Neurblastma Therapy (NANT) treatment prtcl. The wrd yu used thrughut this dcument
More informationIschemic heart disease (angina/chest pain)
Ischemic heart disease (angina/chest pain) External resurces Stable angina: management NICE guidelines [CG126] Updated :Aug 2016 https://www.nice.rg.uk/guidance/cg126 Chest pain f recent nset [CG95] Nvember
More information2017 Optum, Inc. All rights reserved BH1124_112017
1) What are the benefits t clients f encuraging the use f MAT? Withut MAT, 90% f individuals with Opiid Use Disrder (OUD) will relapse within ne year. With MAT, the relapse rate fr thse with OUD decreases
More information3903 Fair Ridge Drive, Suite 209, Fairfax, VA Harry Byrd Hwy, Suite 285, Ashburn, VA *How did you hear about our program?
3903 Fair Ridge Drive, Suite 209, Fairfax, VA 22033 44121 Harry Byrd Hwy, Suite 285, Ashburn, VA 220147 *Hw did yu hear abut ur prgram? Patient Histry Patient Name: First Middle: Last: Address: City: State:
More informationAsthma inhalers, medicines and treatments
Asthma inhalers, medicines and treatments Reliever inhalers Yur Emergency Rescue Reliever Everyne with asthma shuld ALWAYS carry a reliever (blue inhaler) inhaler at all the time s it s n hand in an emergency
More informationHealth for Life Chiropractic At Cloverdale Mall Unit # The East Mall Etobicoke, ON, M9B 3Y
Health fr Life Chirpractic At Clverdale Mall Unit #143-250 The East Mall Etbicke, ON, M9B 3Y8 416-232-1822 416-232-0060 Child and Adlescent Health Questinnaire Name:_ Birth date: Address:_ Telephne: Medical
More informationCONTACT: Amber Hamilton TYPE 2 DIABETES AND OBESITY: TWIN EPIDEMICS OVERVIEW
FACT SHEET CONTACT: Amber Hamiltn 212-266-0062 TYPE 2 DIABETES AND OBESITY: TWIN EPIDEMICS OVERVIEW Type 2 diabetes accunts fr 90-95% f the 29.1 millin diabetes cases in the U.S. 1 Obesity is a majr independent
More informationContinuous Quality Improvement: Treatment Record Reviews. Third Thursday Provider Call (August 20, 2015) Wendy Bowlin, QM Administrator
Cntinuus Quality Imprvement: Treatment Recrd Reviews Third Thursday Prvider Call (August 20, 2015) Wendy Bwlin, QM Administratr Gals f the Presentatin Review the findings f Treatment Recrd Review results
More informationHuman papillomavirus (HPV) refers to a group of more than 150 related viruses.
HUMAN PAPILLOMAVIRUS This infrmatin may help answer sme f yur questins and help yu think f ther questins that yu may want t ask yur cancer care team; it is nt intended t replace advice r discussin between
More informationManaging the Symptoms of Stroke
Unit 26: Recgnising and Managing the Symptms f Strke Unit reference number: F/616/7312 Level: 2 Unit type: Optinal Credit value: 3 Guided learning hurs: 28 Unit summary A strke can be a life-threatening
More informationPsychological aspects of breast cancer. Dr Caroline Dancyger & Dr Esther Hansen
Psychlgical aspects f breast cancer Dr Carline Dancyger & Dr Esther Hansen Cmmn acrss all cancers Adjustment as the nrm Diagnsis End f active treatment r Discharge Palliative Care Recurrence distress t
More informationIndividual Assessments for Couples Treatment with HFCA
Individual Assessments fr Cuples Treatment with HFCA Jennifer S. Ripley, Ph.D. Many appraches t cuples therapy include an individual assessment whenever a cuple cmes fr treatment. Therapists shuld be aware
More informationIntravenous Vancomycin Use in Adults Intermittent (Pulsed) Infusion
Backgrund This plicy cvers the use f intravenus vancmycin prescribed as an intermittent (pulsed) infusin. This can be used fr treatment r prphylaxis. Evidence supprting this guidance is detailed belw.
More informationOpioid Analgesics PA Request Provider Checklist
WVP Health Authrity Updated 05-12-2015 Opiid Analgesics PA Request Prvider Checklist *** If pssible, please include the fllwing infrmatin with PA requests fr piid analgesics. Including the requested infrmatin
More informationInfluenza (Flu) Fact Sheet
Influenza (Flu) Fact Sheet What is the flu? The flu is a cntagius respiratry illness caused by influenza viruses. It can cause mild t severe illness, and at times can lead t death. Sme peple, such as lder
More informationRoActemra (tocilizumab) for Giant Cell Arteritis (GCA) subcutaneous (SC) formulation
RActemra (tcilizumab) fr Giant Cell Arteritis (GCA) subcutaneus (SC) frmulatin What yu shuld knw abut RActemra This brchure prvides key infrmatin t assist in the patient s understanding f the benefits
More informationThe principles of evidence-based medicine
The principles f evidence-based medicine By the end f this mdule yu shuld be able t: Describe what evidence based medicine is Knw where t find quality evidenced based medicine n the internet Be able t
More informationModule 6: Goal Setting
Mdule 6: Gal Setting Objectives T understand the cncept f gal setting in Brief CBT T acquire skills t set feasible and apprpriate gals in Brief CBT What is gal setting, and why is it imprtant t set gals
More informationMEDICATION GUIDE LEMTRADA (lem-tra-da) (alemtuzumab) Injection for intravenous infusion
MEDICATION GUIDE LEMTRADA (lem-tra-da) (alemtuzumab) Injectin fr intravenus infusin Read this Medicatin Guide befre yu start receiving LEMTRADA and befre yu begin each treatment curse. There may be new
More informationMedication Assisted Treatment for Opioid Use Disorder in Rural Colorado
Medicatin Assisted Treatment fr Opiid Use Disrder in Rural Clrad Why is piid use disrder getting s much attentin? Opiid Use Disrder (OUD) has seen an epidemic rise in the United States ver the past decade.
More informationEating Disorders. what do GPs need to know? John O Brien May 2016
Eating Disrders what d GPs need t knw? Jhn O Brien May 2016 Overview Eating, weight and eating disrders Case scenari Hw t spt them When t refer Management pre and pst referral Eating and weight Adlescence
More informationFamily Medicine Clinical Pharmacy Forum Vol. 3, Issue 5 (September/October 2007)
1 Family Medicine Clinical Pharmacy Frum Vl. 3, Issue 5 (September/Octber 2007) Family Medicine Clinical Pharmacy Frum is a brief bi-mnthly publicatin frm the Family Medicine clinical pharmacists distributed
More informationPercutaneous Nephrolithotomy (PCNL)
Percutaneus Nephrlithtmy (PCNL) What is a percutaneus nephrlithtmy? is the mst effective f the cmmnly perfrmed prcedures fr kidney stnes. It is the best prcedure fr large and cmplex stnes. T perfrm this
More informationFor our protection, we require verification that you have received this notice. Therefore, please sign below.
PATIENT INFORMATION Dear Patient: Sleep prblems are extremely cmmn. Public health and safety are threatened by the increasing prevalence f bstructive sleep apnea, which nw afflicts at least 25 millin adults
More informationPost-Operative Spine Care
Pst-Operative Spine Care Activity: Yu will need t avid bending, lifting, twisting, and sudden mvements fr three weeks after surgery Sitting, specially if leaning frward, results in the greatest frces being
More informationCONSENT FORM - TESTOSTERONE FOR TRANSGENDER CLIENTS
CONSENT FORM - TESTOSTERONE FOR TRANSGENDER CLIENTS Yu want t take teststerne t masculinize yur bdy. Befre taking it, there are several things yu need t knw abut. They are the pssible advantages, disadvantages,
More informationFor our protection, we require verification that you have received this notice. Therefore, please sign below.
PATIENT INFORMATION Dear Patient: Sleep prblems are extremely cmmn. Public health and safety are threatened by the increasing prevalence f bstructive sleep apnea, which nw afflicts at least 25 millin adults
More informationSUMMACARE COMMERCIAL MEDICATION REQUEST GUIDELINES. ANTI-OBESITY AGENTS Generic Brand HICL GCN Exception/Other QSYMIA 32515, 32744, 32746, 32745
Generic Brand HICL GCN Exceptin/Other NALTREXONE CONTRAVE ER 41389 /BUPROPION LORCASERIN BELVIQ 34733 PHENTERMINE PHENTERMINE 20691 20692 20693 20713 PHENTERMINE LOMAIRA 20715 PHENTERMINE/TO PIRAMATE GUIDELINES
More informationTop 10 Causes of Disability
Tp 10 Causes f Disability Disability can happen t anyne, f any age. Thugh sme may be the result f accidents r injuries that are unavidable, many disabilities are the result f diseases and health cnditins
More informationLYME DISEASE (taken from 6/20/13)
LYME DISEASE (taken frm www.lymemd.rg 6/20/13) PREVENTING LYME DISEASE Understand the risks The risk f Lyme disease is year rund. Highest risk late spring t early summer. Learn t enjy the utdrs SAFELY.
More informationReferral Criteria: Inflammation of the Spine Feb
Referral Criteria: Inflammatin f the Spine Feb 2019 1 5.7. Inflammatin f the Spine Backgrund Ankylsing spndylitis and axial spndylarthrpathy are fund in arund 0.3-1.2% f the ppulatin. Spndylarthritis encmpasses
More informationRisk factors in health and disease
Risk factrs in health and disease Index 1 Intrductin 2 Types f risk factrs 2.1 Behaviural risk factrs 2.2 Psychlgical risk factrs 2.3 Demgraphic risk factrs 2.4 Envirnmental risk factrs 2.5 Genetic risk
More informationTOP TIPS Lung Cancer Update Dr Andrew Wight Consultant respiratory Physician - WUTH
Tpic Circulatin list In case f query please cntact Executive Summary TOP TIPS Lung Cancer Update Dr Andrew Wight Cnsultant respiratry Physician - WUTH All Wirral GP s JaneFletcher2@nhs.net Dear Clleagues,
More informationIntravenous Vancomycin Use in Adults Intermittent (Pulsed) Infusion
Intravenus Vancmycin Use in Adults Intermittent (Pulsed) Infusin Backgrund This plicy cvers the use f intravenus vancmycin prescribed as an intermittent (pulsed) infusin. This can be used fr treatment
More informationPackage leaflet: Information for the user. Dacepton 5 mg/ml Solution for infusion Apomorphine hydrochloride hemihydrate
Package leaflet: Infrmatin fr the user Daceptn 5 mg/ml Slutin fr infusin Apmrphine hydrchlride hemihydrate Read all f this leaflet carefully befre yu start using this medicine because it cntains imprtant
More informationTick fever is a cattle disease caused by any one of the following blood parasites:
Tick fever Tick fever is a cattle disease caused by any ne f the fllwing bld parasites: Babesia bvis Babesia bigemina Anaplasma marginale These parasites are all transmitted by the cattle tick (Bphilus
More informationMy Symptoms and Medical History for Adult Chronic Immune Thrombocytopenia (ITP)
My Symptms and Medical Histry fr Adult Chrnic Immune Thrmbcytpenia (ITP) Call t talk t a registered nurse 1-855-7Nplate (1-855-767-5283), Mnday Friday, 9:00 AM 9:00 PM ET Indicatin Nplate is a man-made
More informationCall a healthcare provider right away if you have any of the following s ymptoms, es pecially if they are new, wors e, or worry you:
MEDICATION GUIDE EMSAM [EM sam] (selegiline transdermal system) Read this Medicatin Guide carefully befre yu start using EMSAM and each time yu get a refill. There may be new infrmatin. This infrmatin
More informationAccess to Heme Treatment in Canada - Survey 2018
Access t Heme Treatment in Canada - Survey 2018 The Canadian Assciatin fr Prphyria/Assciatin Canadienne de Prphyrie (CAP/ACP) asserts that patients with acute prphyria shuld have access t Hemin treatment,
More informationMEDICATION GUIDE REVLIMID (rev-li-mid) (lenalidomide) capsules What is the most important information I should know about REVLIMID?
MEDICATION GUIDE REVLIMID (rev-li-mid) (lenalidmide) capsules What is the mst imprtant infrmatin I shuld knw abut REVLIMID? Befre yu begin taking REVLIMID, yu must read and agree t all f the instructins
More informationThese are medical emergencies that can cause death. If possible, remove OTFC from the mouth.
MEDICATION GUIDE Oral Transmucsal Fentanyl Citrate (OTFC) CII (fentanyl citrate) ral transmucsal lzenge 200 mcg, 400 mcg, 600 mcg, 800 mcg, 1200 mcg, 1600 mcg IMPORTANT: D nt use Oral Transmucsal Fentanyl
More informationRequest for Prior Authorization for Click here to enter text. Website Form Submit request via: Fax
Request fr Prir Authrizatin fr Click here t enter text. Website Frm www.highmarkhealthptins.cm Submit request via: Fax - 1-855-476-4158 Updated: 05/2018 DMMA Apprved: 05/2018 All requests fr Intravenus
More informationFormulary and Prescribing Guidelines
SECTION 7: MANAGEMENT OF DEMENTIA Frmulary and Prescribing Guidelines 7.1 Apprved drugs fr use in cgnitive impairment f Alzheimer s disease Drug 3 Frmulatin 3 Dse 3 Licensed 4 Dnepezil Tablets 5 mg, 10
More informationNUCYNTA ER (tapentadol extended-release tablets) Fact Sheet
NUCYNTA ER (tapentadl extended-release tablets) Fact Sheet What is NUCYNTA ER (prnunced 'new-sinn-tah')? NUCYNTA ER (tapentadl extended-release tablets), an ral analgesic taken twice daily, is nw apprved
More informationUS Public Health Service Clinical Practice Guidelines for PrEP
Webcast 1.3 US Public Health Service Clinical Practice Guidelines fr PrEP P R E S ENTED BY: M A R K T H R U N, M D A S S O C I AT E P R O F E S S O R, U N I V E R S I T Y O F C O L O R A D O, D I V I S
More informationRelated Policies None
Medical Plicy MP 3.01.501 Guidelines fr Cverage f Mental and Behaviral Health Services Last Review: 8/30/2017 Effective Date: 8/30/2017 Sectin: Mental Health End Date: 08/19/2018 Related Plicies Nne DISCLAIMER
More informationMEDICATION GUIDE XARELTO (zah-rel-toe) (rivaroxaban) tablets
MEDICATION GUIDE XARELTO (zah-rel-te) (rivarxaban) tablets Read this Medicatin Guide befre yu start taking XARELTO and each time yu get a refill. There may be new infrmatin. This Medicatin Guide des nt
More informationMEDICATION GUIDE SUBOXONE (Sub OX own) (buprenorphine and naloxone) Sublingual Film for Sublingual or Buccal Administration (CIII)
MEDICATION GUIDE SUBOXONE (Sub OX wn) (buprenrphine and nalxne) Sublingual Film fr Sublingual r Buccal Administratin (CIII) IMPORTANT: Keep SUBOXONE sublingual film in a secure place away frm children.
More informationMeeting Minutes. III. New Business (Slide Presentation is embedded for reference) [slides 3-47] May 2011 DMRAB Presentation PUBLIC C
Cmmnwealth f Kentucky Cabinet fr Health and Family Services Department fr Medicaid Services Drug Management Review Advisry Bard Meeting May 12, 2011 Meeting Minutes Vting Members in attendance: Kim Crley,
More informationHead and neck cancers are often treated with radiotherapy. Radiotherapy can lead to faster rates of tooth decay and poor healing in the mouth.
DENTAL EXTRACTION This infrmatin aims t help yu understand the peratin, what is invlved and sme cmmn cmplicatins that may ccur. It may help answer sme f yur questins and help yu think f ther questins that
More informationCDC Influenza Technical Key Points February 15, 2018
CDC Influenza Technical Key Pints In this dcument: Summary Key Pints U.S. Vaccine Effectiveness U.S. Flu Activity Update Summary Key Pints On Thursday, tw influenza-related reprts appeared in the Mrbidity
More informationBefore Your Visit: Mohs Skin Cancer Surgery
Befre Yur Visit: Mhs Skin Cancer Surgery Yur Kaiser Permanente Care Instructins Skin Cancer Infrmatin What is skin cancer? Skin cancers are tumrs, r malignancies, f the skin. Skin cancer is assciated with
More informationAdult Preventive Care Guidelines
Adult Preventive Care Guidelines Gundersen is yur partner fr better health. We want t wrk with yu t make sure that yu and yur family are as healthy as pssible. That can be accmplished best if we wrk tgether
More informationKey Points Enterovirus D68 in the United States, 2014 Note: Newly added information is in red.
Key Pints Entervirus D68 in the United States, 2014 Nte: Newly added infrmatin is in red. The United States is currently experiencing a natinwide utbreak f entervirus D68 (EV-D68) assciated with severe
More informationVaccine Information Statement: PNEUMOCOCCAL CONJUGATE VACCINE
Vaccine Infrmatin Statement: PNEUMOCOCCAL CONJUGATE VACCINE Many Vaccine Infrmatin Statements are available in Spanish and ther languages. See www.immunize.rg/vis. Hjas de Infrmacián Sbre Vacunas están
More informationACSQHC National Consensus Statement: Essential Elements for High Quality End-oflife Care in Acute Hospitals.
27 March 2014 Prfessr Debra Picne Chief Executive Officer Australian Cmmissin n Safety and Quality in Health Care c/ Ms Jennifer Hill, Senir Prject Officer Level 5, 255 Elizabeth Street SYDNEY NSW 2000
More informationWhat is Asthma? A collaborative effort of Children s Hospital of Pittsburgh of UPMC and The Pennsylvania Child Welfare Resource Center
A cllabrative effrt f Children s Hspital f Pittsburgh f UPMC and The Pennsylvania Child Welfare Resurce Center What is Asthma? Jennifer E. Wlfrd, DO, MPH, FAAP Children s Hspital f Pittsburgh, Divisin
More informationBody chemistry and mood How our chemical makeup may affect our emotions. Circadian rhythm
Presentatin: Bdy chemistry and md Bdy chemistry and md Hw ur chemical makeup may affect ur emtins Definitin Circadian rhythm A circadian rhythm is a rughly 24 hur cycle (Circa + Dia = the Circle f a Day)
More informationEvaluation of a Shared Decision Making Intervention between Patients and Providers to Improve Menopause Health Outcomes: Issue Brief
Evaluatin f a Shared Decisin Making Interventin between Patients and Prviders t Imprve Menpause Health Outcmes: Issue Brief Key Findings Tablet technlgy can be successfully incrprated int primary practices
More informationMEDICATION GUIDE. (Interferon alfa-2b)
MEDICATION GUIDE INTRON A (In-trn-aye) (Interfern alfa-2b) Read this Medicatin Guide befre yu start taking INTRON A, and each time yu get a refill. There may be new infrmatin. This infrmatin des nt take
More informationKey Points Enterovirus D68 in the United States, 2014 Note: Newly added information is in red.
Key Pints Entervirus D68 in the United States, 2014 Nte: Newly added infrmatin is in red. Over the last several mnths, the United States has experienced a natinwide utbreak f entervirus D68 (EV- D68) assciated
More information2018 CMS Web Interface
CMS Web Interface MH-1 (NQF 0710): Depressin Remissin at Twelve Mnths Measure Steward: MNCM CMS Web Interface V2.0 Page 1 f 27 11/13/2017 Cntents INTRODUCTION... 4 CMS WEB INTERFACE SAMPLING INFORMATION...
More informationMedication Guide ABSTRAL (AB-stral) CII (fentanyl) Sublingual tablets
Medicatin Guide ABSTRAL (AB-stral) CII (fentanyl) Sublingual tablets IMPORTANT: D nt use ABSTRAL unless yu are regularly using anther piid pain medicine arund-the-clck fr at least ne week r lnger fr yur
More information